Hepatic phosphoserine aminotransferase 1 regulates insulin sensitivity in mice via tribbles homolog 3

Diabetes

Volumn 64, Issue 5, 2015, Pages 1591-1602

  Yu, Junjie ^a   Xiao, Fei ^a   Guo, Yajie ^a   Deng, Jiali ^a   Liu, Bin ^a   Zhang, Qian ^a   Li, Kai ^a   Wang, Chunxia ^a   Chen, Shanghai ^a   Guo, Feifan ^a  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; INSULIN; LIVER ENZYME; NONESSENTIAL AMINO ACID; PHOSPHOSERINE AMINOTRANSFERASE 1; PROTEIN; PROTEIN KINASE B; SERINE; SHORT HAIRPIN RNA; TRIBBLES HOMOLOG 3; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; FAT INTAKE; GLUCOSE BLOOD LEVEL; PHOSPHOSERINE AMINOTRANSFERASE; TRB3 PROTEIN, MOUSE;

ADENOVIRIDAE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLYCOGEN ANALYSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INTRACELLULAR SIGNALING; LIPID DIET; LIVER CELL; LIVER CELL CARCINOMA; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WHITE ADIPOSE TISSUE; ADVERSE EFFECTS; ANIMAL; BLOOD; C57BL MOUSE; CELL CULTURE; ENZYMOLOGY; FAT INTAKE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HEPG2 CELL LINE; METABOLISM; NONOBESE DIABETIC MOUSE;

ANIMALS; BLOOD GLUCOSE; CELL CYCLE PROTEINS; CELLS, CULTURED; DIETARY FATS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE KNOCKDOWN TECHNIQUES; GLUCOSE TOLERANCE TEST; HEP G2 CELLS; HEPATOCYTES; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; TRANSAMINASES;

EID: 84933512062     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1368     Document Type: Article

References (45)

1. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001;414:799-806.
2. Kelly GS. Insulin resistance: lifestyle and nutritional interventions. Altern Med Rev 2000;5:109-132.
3. Moloney F, Yeow TP, Mullen A, Nolan JJ, Roche HM. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr 2004;80:887-895.
4. McKeown NM, Meigs JB, Liu S, Saltzman E, Wilson PW, Jacques PF. Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. Diabetes Care 2004;27:538-546.
5. Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009;9:311-326.
6. Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011;17:448-453.
7. Xiao F, Huang Z, Li H, et al. Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways. Diabetes 2011;60:746-756.
8. Floegel A, Stefan N, Yu Z, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 2013;62:639-648.
9. Prada PO, Hirabara SM, de Souza CT, et al. L-glutamine supplementation induces insulin resistance in adipose tissue and improves insulin signalling in liver and muscle of rats with diet-induced obesity. Diabetologia 2007;50:1949-1959.
10. Baek JY, Jun DY, Taub D, Kim YH. Characterization of human phosphoserine aminotransferase involved in the phosphorylated pathway of L-serine biosynthesis. Biochem J 2003;373:191-200.
11. Snell K. Enzymes of serine metabolism in normal, developing and neoplastic rat tissues. Adv Enzyme Regul 1984;22:325-400.
12. Basurko MJ, Marche M, Darriet M, Cassaigne A. Phosphoserine aminotransferase, the second step-catalyzing enzyme for serine biosynthesis. IUBMB Life 1999;48:525-529.
13. Kalhan SC, Hanson RW. Resurgence of serine: An often neglected but indispensable amino Acid. J Biol Chem 2012;287:19786-19791.
14. Possemato R, Marks KM, Shaul YD, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 2011;476: 346-350.
15. Maddocks OD, Berkers CR, Mason SM, et al. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 2013; 493:542-546.
16. Bismut H, Plas C. Role of serine biosynthesis and its utilization in the alternative pathway from glucose to glycogen during the response to insulin in cultured foetalrat hepatocytes. Biochem J 1991;276:577-582.
17. Hart CE, Race V, Achouri Y, et al. Phosphoserine aminotransferase deficiency: A novel disorder of the serine biosynthesis pathway. Am J Hum Genet 2007;80:931-937.
18. Vié N, Copois V, Bascoul-Mollevi C, et al. Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells. Mol Cancer 2008;7:14.
19. Ozeki Y, Pickard BS, Kano S, et al. A novel balanced chromosomal translocation found in subjects with schizophrenia and schizotypal personality disorder: Altered l-serine level associated with disruption of PSAT1 gene expression. Neurosci Res 2011;69:154-160.
20. Rabaglia ME, Gray-Keller MP, Frey BL, Shortreed MR, Smith LM, Attie AD. Alpha-Ketoisocaproate-induced hypersecretion of insulin by islets from diabetessusceptible mice. Am J Physiol Endocrinol Metab 2005;289:E218-E224.
21. Kalhan SC, Uppal SO, Moorman JL, et al. Metabolic and genomic response to dietary isocaloric protein restriction in the rat. J Biol Chem 2011;286:5266- 5277.
22. Larivière F, Chiasson JL, Schiffrin A, Taveroff A, Hoffer LJ. Effects of dietary protein restriction on glucose and insulin metabolism in normal and diabetic humans. Metabolism 1994;43:462-467.
23. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 1988;37:1163-1167.
24. Sun C, Zhang F, Ge X, et al. SIRT1 improves insulin sensitivity under insulinresistant conditions by repressing PTP1B. Cell Metab 2007;6:307-319.
25. Wang Q, Jiang L, Wang J, et al. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptordeficient mice. Hepatology 2009;49:1166-1175.
26. Inoue T, Hamase K, Morikawa A, Zaitsu K. Determination of minute amounts of D-leucine in various brain regions of rat and mouse using column-switching high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 2000; 744:213-219.
27. Guo F, Cavener DR. The GCN2 eIF2alpha kinase regulates fatty- Acid homeostasis in the liver during deprivation of an essential amino acid. Cell Metab 2007;5:103-114.
28. Kodama H, Fujita M, Yamaguchi I. Development of hyperglycaemia and insulin resistance in conscious genetically diabetic (C57BL/KsJ-db/db) mice. Diabetologia 1994;37:739-744.
29. Winzell MS, Ahrén B. The high-fat diet-fed mouse: A model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 2004;53(Suppl.3):S215-S219.
30. Radziuk J, Pye S. Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis. Diabetes Metab Res Rev 2001;17:250-272.
31. Roach PJ, Depaoli-Roach AA, Hurley TD, Tagliabracci VS. Glycogen and its metabolism: some new developments and old themes. Biochem J 2012;441: 763-787.
32. Gulick T, Cresci S, Caira T, Moore DD, Kelly DP. The peroxisome proliferator- Activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci U S A 1994;91:11012-11016.
33. Du K, Herzig S, Kulkarni RN, Montminy M. TRB3: A tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 2003;300:1574-1577.
34. Ye J, Mancuso A, Tong X, et al. Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc Natl Acad Sci U S A 2012;109:6904-6909.
35. Ohoka N, Yoshii S, Hattori T, Onozaki K, Hayashi H. TRB3, a novel ER stressinducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J 2005;24:1243-1255.
36. Yang L, Li P, Fu S, Calay ES, Hotamisligil GS. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab 2010;11: 467-478.
37. Matsumoto M, Han S, Kitamura T, Accili D. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest 2006;116:2464-2472.
38. White JK, Gerdin AK, Karp NA, et al.; Sanger Institute Mouse Genetics Project. Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes. Cell 2013;154:452-464.
39. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006;116:1793-1801.
40. Cheung AT, Wang J, Ree D, Kolls JK, Bryerash M. Tumor necrosis factoralpha induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase. Diabetes 2000;49:810-819.
41. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006;7:85-96.
42. Okamoto H, Latres E, Liu R, et al. Genetic deletion of Trb3, the mammalian Drosophila tribbles homolog, displays normal hepatic insulin signaling and glucose homeostasis. Diabetes 2007;56:1350-1356.
43. Koo SH, Satoh H, Herzig S, et al. PGC-1 promotes insulin resistance in liver through PPAR- Alpha-dependent induction of TRB-3. Nat Med 2004;10: 530-534.
44. Ma L, Tao Y, Duran A, et al. Control of nutrient stress-induced metabolic reprogramming by PKCz in tumorigenesis. Cell 2013;152:599-611.
45. Carraro V, Maurin AC, Lambert-Langlais S, et al. Amino acid availability controls TRB3 transcription in liver through the GCN2/eIF2a/ATF4 pathway. PLoS ONE 2010;5:e15716.